Ni M - Search Results

1

Proteomic analysis reveals CAAP1 negatively correlates with platinum resistance in ovarian cancer.

Ni M, Zhou J, Gong W, Jiang R, Li X, Dai W, Yin Z, Chen Z, Zheng Z, Zhu J. Ni M, et al. J Proteomics. 2023 Apr 15;277:104864. doi: 10.1016/j.jprot.2023.104864. Epub 2023 Mar 2. J Proteomics. 2023. PMID: 36870674

2

The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer.

Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu LH, Chen W, Wang LY, Zhao Y, Tian B, Hua YJ. Zheng ZG, et al. Sci Rep. 2016 May 19;6:26093. doi: 10.1038/srep26093. Sci Rep. 2016. PMID: 27193186 Free PMC article.

3

Modified filter-aided sample preparation (FASP) method increases peptide and protein identifications for shotgun proteomics.

Ni MW, Wang L, Chen W, Mou HZ, Zhou J, Zheng ZG. Ni MW, et al. Rapid Commun Mass Spectrom. 2017 Jan 30;31(2):171-178. doi: 10.1002/rcm.7779. Rapid Commun Mass Spectrom. 2017. PMID: 27794190

4

Curcumol Promotes Vascular Endothelial Growth Factor (VEGF)-Mediated Diabetic Wound Healing in Streptozotocin-Induced Hyperglycemic Rats.

Zhou J, Ni M, Liu X, Ren Z, Zheng Z. Zhou J, et al. Among authors: ni m. Med Sci Monit. 2017 Jan 31;23:555-562. doi: 10.12659/msm.902859. Med Sci Monit. 2017. PMID: 28138126 Free PMC article.

5

Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.

Ni MW, Zhou J, Li H, Chen W, Mou HZ, Zheng ZG. Ni MW, et al. Bioanalysis. 2017 Jun;9(12):925-935. doi: 10.4155/bio-2017-0031. Epub 2017 Jun 15. Bioanalysis. 2017. PMID: 28617069

6

Downregulation of LINC00515 in high-grade serous ovarian cancer and its relationship with platinum resistance.

Ni MW, Zhou J, Zhang YL, Zhou GM, Zhang SJ, Feng JG, Xu Q, Zhou Y, Mou HZ, Zheng ZG. Ni MW, et al. Biomark Med. 2019 May;13(7):535-543. doi: 10.2217/bmm-2018-0382. Epub 2019 May 29. Biomark Med. 2019. PMID: 31140829

7

Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer.

Gong W, Ni M, Chen Z, Zheng Z. Gong W, et al. Among authors: ni m. Oncol Lett. 2020 Sep;20(3):2749-2756. doi: 10.3892/ol.2020.11836. Epub 2020 Jul 9. Oncol Lett. 2020. PMID: 32782591 Free PMC article.

8

Characterisation of naturally occurring isothiocyanates as glutathione reductase inhibitors.

Li X, Ni M, Xu X, Chen W. Li X, et al. Among authors: ni m. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1773-1780. doi: 10.1080/14756366.2020.1822828. J Enzyme Inhib Med Chem. 2020. PMID: 32951477 Free PMC article.

9

A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.

Ni M, Zhou J, Zhu Z, Yuan J, Gong W, Zhu J, Zheng Z, Zhao H. Ni M, et al. Front Cell Dev Biol. 2021 Aug 30;9:712196. doi: 10.3389/fcell.2021.712196. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34527671 Free PMC article.

10

Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.

Li X, Ma Y, Wu J, Ni M, Chen A, Zhou Y, Dai W, Chen Z, Jiang R, Ling Y, Yao Q, Chen W. Li X, et al. Among authors: ni m. Drug Resist Updat. 2023 Mar;67:100930. doi: 10.1016/j.drup.2023.100930. Epub 2023 Jan 20. Drug Resist Updat. 2023. PMID: 36736043 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,728 results

Search Page

Filters